These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 8210589

  • 1. Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging.
    Goldberg MA, Lee MJ, Fischman AJ, Mueller PR, Alpert NM, Thrall JH.
    Radiographics; 1993 Sep; 13(5):1047-62. PubMed ID: 8210589
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
    Kim EE, Chung SK, Haynie TP, Kim CG, Cho BJ, Podoloff DA, Tilbury RS, Yang DJ, Yung WK, Moser RP.
    Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
    [Abstract] [Full Text] [Related]

  • 3. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver.
    Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK, Chapman WC, Pinson CW.
    Am J Surg; 1996 Jan; 171(1):21-6. PubMed ID: 8554144
    [Abstract] [Full Text] [Related]

  • 4. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy.
    Torizuka T, Tamaki N, Inokuma T, Magata Y, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J.
    J Nucl Med; 1994 Dec; 35(12):1965-9. PubMed ID: 7989978
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment.
    Okazumi S, Isono K, Enomoto K, Kikuchi T, Ozaki M, Yamamoto H, Hayashi H, Asano T, Ryu M.
    J Nucl Med; 1992 Mar; 33(3):333-9. PubMed ID: 1311035
    [Abstract] [Full Text] [Related]

  • 6. The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver.
    Zhuang H, Sinha P, Pourdehnad M, Duarte PS, Yamamoto AJ, Alavi A.
    Nucl Med Commun; 2000 Sep; 21(9):793-8. PubMed ID: 11065150
    [Abstract] [Full Text] [Related]

  • 7. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS, Francis IR, Kaminski MS, Wahl RL.
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [Abstract] [Full Text] [Related]

  • 8. Similar pelvic abnormalities on FDG positron emission tomography of different origins.
    Zhuang H, Yamamoto AJ, Sinha P, Pourdehnad M, Liu Y, Alavi A.
    Clin Nucl Med; 2001 Jun; 26(6):515-7. PubMed ID: 11353298
    [Abstract] [Full Text] [Related]

  • 9. FDG-PET appearance of pelvic Castleman's disease.
    Murphy SP, Nathan MA, Karwal MW.
    J Nucl Med; 1997 Aug; 38(8):1211-2. PubMed ID: 9255152
    [Abstract] [Full Text] [Related]

  • 10. A case of cavernous hemangioma in which malignancy was preoperatively excluded by FDG-PET.
    Higashiyama S, Kawabe J, Hayashi T, Kurooka H, Oe A, Kotani J, Kawamura E, Shiomi S.
    Ann Nucl Med; 2008 May; 22(4):327-30. PubMed ID: 18535885
    [Abstract] [Full Text] [Related]

  • 11. In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET.
    Torizuka T, Tamaki N, Inokuma T, Magata Y, Sasayama S, Yonekura Y, Tanaka A, Yamaoka Y, Yamamoto K, Konishi J.
    J Nucl Med; 1995 Oct; 36(10):1811-7. PubMed ID: 7562048
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis of liver tumors with 18F-FDG and 18F-FDGal using PET].
    Fukuda H.
    Nihon Rinsho; 1991 Aug; 49(8):1863-7. PubMed ID: 1664893
    [No Abstract] [Full Text] [Related]

  • 13. [Nuclear medical diagnostics for liver tumors].
    Buck AK, Stollfuss JC, Stahl A, Beer AJ, Meisetschläger G, Schwaiger M.
    Internist (Berl); 2007 Jan; 48(1):21-4, 26-9. PubMed ID: 17195061
    [Abstract] [Full Text] [Related]

  • 14. Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms.
    Gupta N, Bradfield H.
    Semin Nucl Med; 1996 Jan; 26(1):65-73. PubMed ID: 8623053
    [Abstract] [Full Text] [Related]

  • 15. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis.
    Okada J, Yoshikawa K, Imazeki K, Minoshima S, Uno K, Itami J, Kuyama J, Maruno H, Arimizu N.
    J Nucl Med; 1991 Apr; 32(4):686-91. PubMed ID: 2013808
    [Abstract] [Full Text] [Related]

  • 16. [Current status of positron emission tomography in diagnosis of abdominal tumors].
    Reske SN.
    Praxis (Bern 1994); 1999 Jan 14; 88(3):52-8, 60-4. PubMed ID: 10067106
    [Abstract] [Full Text] [Related]

  • 17. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
    Shulkin BL, Mitchell DS, Ungar DR, Prakash D, Dole MG, Castle VP, Hernandez RJ, Koeppe RA, Hutchinson RJ.
    Radiology; 1995 Feb 14; 194(2):495-500. PubMed ID: 7824731
    [Abstract] [Full Text] [Related]

  • 18. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study.
    Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z.
    Colorectal Dis; 2011 Nov 14; 13(11):e374-8. PubMed ID: 21831098
    [Abstract] [Full Text] [Related]

  • 19. False-negative fluorine-18-FDG PET in metastatic carcinoid.
    Jadvar H, Segall GM.
    J Nucl Med; 1997 Sep 14; 38(9):1382-3. PubMed ID: 9293792
    [Abstract] [Full Text] [Related]

  • 20. FDG PET for giant cavernous hemangioma: important clue to differentiate from a malignant vascular tumor in the liver.
    Shimada K, Nakamoto Y, Isoda H, Saito H, Arizono S, Shibata T, Togashi K.
    Clin Nucl Med; 2010 Dec 14; 35(12):924-6. PubMed ID: 21206221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.